Remy et al, “Apports et perspectives des dérivé de l'hémoglobine”. Schweiz Med Wochenschr, 1997, pp. 1088-1096, vol. 127. |
Hartman et al., “Reduced Nitric Oxide Reactivity of a New Recombinant Human Hemoglobin Attenuates Gastric Dysmotility.” European Journal of Pharmacology, 1998, pp. 175-178, vol. 363. |
Huisman T., “Recombinant Hemoglobin Variants”. Hemoblobin, 1998, pp. 99-112, vol. 22, No. 2. |
Deligné, P., “Quoi de neuf 1990 en matiére de substituts de sang? I. Améliorations des solutions d' heémoglobin modifiée et hémoglobines issues de la bio-ingénierie et du génie génétique.” Urgences, 1990, pp. 76-85, vol. 9. |
Cupane et al. “Modification of α-chain Heme Pocket Polarity by Val(E11) Thr Substitution has Different Effects on the Steric, Dynamic, and Functional Properties of Human Recombinant Hemoglobin.” The Journal of Biological Chemistry, 1997, pp. 26271-26278, vol. 272, No. 42. |
Moore, et al., “Cooperativity in the Dissociation of Nitric Oxide From Hemoglobin.” The Journal of Biological Chemistry, 1976, pp. 2788-2794, vol. 251, No. 9, Waverly Press, Inc., Baltimore. |
Walder, et al. “Development of Antisickling Compounds that Chemically Modify Hemoglobin S Specifically within the 2,3-Diphosphoglycerate Binding Site”. J. Mol. Biol., 1980, vol. 141, pp. 195-216, Acedemic Press, Inc. (London) Ltd. |
Doyle, et al., “Oxidation of Nitrogen Oxides by Bound Dioxygen in Hemoproteins.” Journal of Inorganic Biochemistry, 1981, pp. 351-358, vol. 14, Elsevier North Holland, Inc., New York. |
Feola, et al. “Clinical Trial of a Hemoglobin Based Blood Substitute in Patients with Sickle Cell Anemia”. Surgery, Gynecology & Obstetrics, 1992, vol. 174, pp. 379-386. |
Looker, et al., “A Human Recombinant Haemoglobin Designed for use as a Blood Substitute.” Letters to Nature, 1992, vol. 356, pp. 258-260. |
Conklin, et al. “Effects of Recombinant Human Hemoglobin on Motor Functions of the Opossum Esophagus.” The Journal of Pharmacology and Experimental Theraputice, 1995, vol. 273, No. 2, pp. 762-767. |
Tsuchida, E., “Introduction: Overview and Perspectives”. Artificial Red Cells: Materials, Performances and Clinical Study as Blood Substitutes, Liely, New York, NY, pp 1-20, 1995. |
Eich, et al., “Mechanism of NO-Induced Oxidation of Myoglobin and Hemoglobin.” Biochemistry, 1996, vol. 35, pp. 6676-6983. |
Conover, et al., “The Influence of Polyethylene Glycol Conjugation on Bovine Hemoglobin's Intrinsic Effect on the Gastrointestinal System of the Rat.” Life Science, 1996, vol. 59, No. 22, pp. 1861-1869. |
Gould et al., “Clinical Development of Human Polymerized Hemoglobin as a Blood Substitute.” World Journal of Surgery, 1996, vol. 20, No. 9, pp. 1200-1207. |
Reddy, et al., “Role of β87 Thr in The β6 Val Acceptor Site during Deoxy Hb S Polymerization.” Biochemistry, 1997, vol. 36, pp. 15992-15998. |
Viele, et al., “Recombinant Human Hemoglobin Does not Affect Renal Function in Humans: Analysis of Safety and Pharmacokinetics.” Anesthesiology, 1997, vol. 86, No. 4, pp. 848-858. |